06132.HK
HJ SCIENCE-B
HKSE · Healthcare · Biotechnology · CN
HKD 42.38
+0.95%Margins
Gross margin
100.0%
EBITDA margin
-944.6%
EBIT margin
-959.4%
Net margin
-1033.5%
FCF margin
-625.3%
-12.0%
Return on equity
-11.1%
Return on assets
-10.9%
Return on invested capital
0.01x
Asset turnover
-HKD 99.5M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026